{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:37:51Z","timestamp":1793047071997,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["ZRJY2024-GG08"],"award-info":[{"award-number":["ZRJY2024-GG08"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jaut.2026.103635","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:50:53Z","timestamp":1790110253000},"page":"103635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of clinical-immunologic clusters and anti-RNP\/Ro52 antibody profiles with prognostic trajectories in primary Sj\u00f6gren's disease"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6660-2237","authenticated-orcid":false,"given":"Bojie","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-3248","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2366-5147","authenticated-orcid":false,"given":"Xinbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8935-7453","authenticated-orcid":false,"given":"Chunxin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1643-5450","authenticated-orcid":false,"given":"Jiaqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7784-5904","authenticated-orcid":false,"given":"Xuanyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4367-720X","authenticated-orcid":false,"given":"Zihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7025-1022","authenticated-orcid":false,"given":"Jiahe","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3343-1859","authenticated-orcid":false,"given":"Xiya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-9724","authenticated-orcid":false,"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4588-480X","authenticated-orcid":false,"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9163-8426","authenticated-orcid":false,"given":"Qingwen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2454-2168","authenticated-orcid":false,"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2026.103635_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40744-023-00611-8","article-title":"Epidemiology of Sj\u00f6gren's: a systematic literature review","volume":"11","author":"Thurtle","year":"2024","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.jaut.2026.103635_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","article-title":"Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome","volume":"20","author":"Baldini","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib7","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1093\/rheumatology\/kez052","article-title":"Lymphomas complicating primary Sj\u00f6gren's syndrome: from autoimmunity to lymphoma","volume":"60","author":"Nocturne","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2026.103635_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001033","article-title":"Anti-RNP positivity in primary Sj\u00f6gren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement","volume":"5","author":"Abbara","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2026.103635_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American college of Rheumatology\/European League against rheumatism classification criteria for primary Sj\u00f6gren's Syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102724","article-title":"Anti-Ro60 and anti-Ro52\/TRIM21: two distinct autoantibodies in systemic autoimmune diseases","volume":"124","author":"Lee","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2026.103635_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fimmu.2019.00444","article-title":"Diagnostic utility of separate Anti-Ro60 and Anti-Ro52\/TRIM21 antibody detection in autoimmune diseases","volume":"10","author":"Robbins","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103635_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2026.04.007","article-title":"International expert consensus recommendations on standardised nomenclature of SSA\/Ro (TROVE2\/Ro60 and TRIM21\/Ro52) autoantibodies in autoimmune diseases","author":"Nikolic","year":"2026","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103635_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/art.42789","article-title":"Association of combined Anti-Ro52\/TRIM21 and Anti-Ro60\/SSA antibodies with increased sj\u00f6gren disease severity through Interferon Pathway activation","volume":"76","author":"Bettacchioli","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib9","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103635_bib10","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1007\/s10067-025-07499-5","article-title":"Clinical features of anti-RNP-positive primary Sj\u00f6gren's syndrome","volume":"44","author":"Cheng","year":"2025","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib11","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/S2665-9913(23)00340-5","article-title":"Identification of distinct subgroups of Sj\u00f6gren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts","volume":"6","author":"Nguyen","year":"2024","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152537","article-title":"Clinical stratification of 1318 Primary Sj\u00f6gren's Syndrome patients","volume":"68","author":"Fang","year":"2024","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2026.103635_bib13","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","author":"White","year":"2009","journal-title":"Stat. Med."},{"key":"10.1016\/j.jaut.2026.103635_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.jaut.2026.103635_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.jaut.2026.103635_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64573-9","article-title":"Cox proportional hazards regression in small studies of predictive biomarkers","volume":"14","author":"J\u00f3\u017awiak","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2026.103635_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.jaut.2026.103635_bib18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jclinepi.2013.10.019","article-title":"The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index","volume":"67","author":"Walsh","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jaut.2026.103635_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13293-026-00827-7","article-title":"Sex differences in primary Sj\u00f6gren's disease: prognostic impact on mortality and cancer","volume":"17","author":"Lei","year":"2026","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.jaut.2026.103635_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211020179","article-title":"Ten-year survival analysis of patients with primary Sj\u00f6gren's syndrome in China: a national prospective cohort study","volume":"13","author":"Qian","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jaut.2026.103635_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082620","article-title":"Sj\u00f6gren's Syndrome: the clinical spectrum of Male patients","volume":"9","author":"Chatzis","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2026.103635_bib22","first-page":"2547","article-title":"Impact of gender and age at onset on Sj\u00f6gren's syndrome presentation and outcome: state of the art","volume":"41","author":"Fulvio","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/03009742.2019.1696403","article-title":"Population-based study of patients with primary Sj\u00f6gren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences","volume":"49","author":"Vasaitis","year":"2020","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib24","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1007\/s10067-025-07578-7","article-title":"Clinical characteristics, imaging patterns and management in Male and female patients with primary Sj\u00f6gren's syndrome-associated interstitial lung disease","volume":"44","author":"Zhong","year":"2025","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/art.42238","article-title":"Symptom-Based cluster analysis categorizes Sj\u00f6gren's disease subtypes: an international cohort Study highlighting disease severity and treatment discordance","volume":"74","author":"McCoy","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2026.152942","article-title":"Serological stratification by Anti-Ro52 and Anti-Ro60 profiles reveals distinct systemic phenotypes in primary Sj\u00f6gren's disease","volume":"77","author":"Zhang","year":"2026","journal-title":"Semin. Arthritis Rheum."},{"issue":"Suppl 112","key":"10.1016\/j.jaut.2026.103635_bib27","first-page":"198","article-title":"Phenotyping Sj\u00f6gren's syndrome: towards a personalised management of the disease","volume":"36","author":"Brito-Zer\u00f3n","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102447","article-title":"Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj\u04e7gren's syndrome: a systematic review from the Italian Society of Rheumatology","volume":"19","author":"Sambataro","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2026.103635_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103220","article-title":"Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis","volume":"146","author":"Chevalier","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2026.103635_bib31","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1212\/WNL.0000000000007188","article-title":"Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies","volume":"92","author":"Casal-Dominguez","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2026.103635_bib32","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s10067-018-4111-5","article-title":"Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population-based study","volume":"37","author":"Dai","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/RHU.0000000000001127","article-title":"Characterization of interstitial lung disease associated with anti-ribonucleoprotein antibodies","volume":"26","author":"Lhote","year":"2020","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib34","article-title":"Characteristics and mortality in primary Sj\u00f6gren syndrome-related interstitial lung disease","volume":"100","author":"Gao","year":"2021","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2026.103635_bib35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/art.21566","article-title":"A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen","volume":"54","author":"Greidinger","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2026.103635_bib36","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood-2005-07-2650","article-title":"U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7","volume":"107","author":"Savarese","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2026.103635_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1823229","article-title":"TLR7 signaling aggravates lung inflammation associated with increased anti-Scl-70 autoantibody production in murine bleomycin-induced systemic sclerosis","volume":"17","author":"Evangelista","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103635_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.102998","article-title":"Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: implications for pathogenic mechanisms in autoimmune diseases imprinted by type I interferon gene dysregulation","volume":"135","author":"Svanberg","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2026.103635_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s42358-022-00248-1","volume":"62","author":"Trevisani","year":"2022","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.jaut.2026.103635_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13075-017-1255-7","article-title":"Cigarette smoking and the risk of primary Sj\u00f6gren's syndrome: a nested case control study","volume":"19","author":"Olsson","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2026.103635_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/acr2.11362","article-title":"Associations between smoking and primary sj\u00f6gren syndrome classification using the sj\u00f6gren's international collaborative clinical alliance cohort","volume":"4","author":"Gebreegziabher","year":"2022","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/art.39432","article-title":"Characteristics and survival of Anti-U1 RNP antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension","volume":"68","author":"Sobanski","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010013","article-title":"The role of Anti-U1 RNP antibody in connective tissue disease-associated pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"12","author":"Xiang","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2026.103635_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004580","article-title":"Impact of autoantibody status on stratifying the risk of organ involvement and mortality in SSc: experience from a multicentre French cohort of 1605 patients","volume":"10","author":"Didier","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2026.103635_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chest.2017.08.014","article-title":"Pulmonary arterial hypertension associated with systemic lupus erythematosus: results from the French pulmonary hypertension registry","volume":"153","author":"Hachulla","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2026.103635_bib46","article-title":"Isolated anti-Ro52 identifies a severe subset of Sj\u00f6gren's syndrome patients","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103635_bib47","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.it.2017.07.005","article-title":"TRIM21 and the function of antibodies inside cells","volume":"38","author":"Rhodes","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2026.103635_bib48","doi-asserted-by":"crossref","first-page":"19985","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"107","author":"Mallery","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2026.103635_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738473","article-title":"TRIM21\/Ro52 - roles in innate immunity and autoimmune disease","volume":"12","author":"Jones","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103635_bib50","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren's Syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103635_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ni.2548","article-title":"Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21","volume":"14","author":"McEwan","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2026.103635_bib52","doi-asserted-by":"crossref","first-page":"36478","DOI":"10.1074\/jbc.M111.241786","article-title":"Anti-Ro52 autoantibodies from patients with Sj\u00f6gren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3\/E2 interface","volume":"286","author":"Espinosa","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2026.103635_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/joim.12375","article-title":"Reduced expression of TRIM21\/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease","volume":"278","author":"Brauner","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2026.103635_bib54","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2026.103635_bib55","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103635_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7523914","article-title":"The increased ratio of blood CD56(bright) NK to CD56(dim) NK is a distinguishing feature of primary Sj\u00f6gren's Syndrome","volume":"2020","author":"Ming","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jaut.2026.103635_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.9292","article-title":"Association of germline variants in natural killer cells with tumor immune microenvironment subtypes, tumor-infiltrating lymphocytes, immunotherapy response, clinical outcomes, and cancer risk","volume":"2","author":"Xu","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jaut.2026.103635_bib58","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2379062","article-title":"In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors","volume":"13","author":"Pesini","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaut.2026.103635_bib59","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3389\/fimmu.2019.02164","article-title":"Autoantibodies to killer Cell immunoglobulin-like receptors in patients with systemic lupus erythematosus induce natural killer Cell hyporesponsiveness","volume":"10","author":"Segerberg","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103635_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633658","article-title":"Increased concentrations of circulating soluble MHC class I-Related chain A (sMICA) and sMICB and modulation of plasma membrane MICA expression: potential mechanisms and correlation with natural killer cell activity in systemic lupus erythematosus","volume":"12","author":"Hervier","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103635_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2026.152986","article-title":"Paraproteinemias in Sj\u00f6gren disease: cryoglobulinemia and serum monoclonal gammopathy identify distinct clinical phenotypes and differential lymphoma susceptibility","volume":"78","author":"Longhino","year":"2026","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2026.103635_bib62","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.annepidem.2013.07.021","article-title":"Quantifying lead-time bias in risk factor studies of cancer through simulation","volume":"23","author":"Jansen","year":"2013","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.jaut.2026.103635_bib63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer","volume":"102","author":"Welch","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaut.2026.103635_bib64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41408-025-01322-9","article-title":"Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection","volume":"15","author":"Atallah-Yunes","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jaut.2026.103635_bib65","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/rheumatology\/keae076","article-title":"Lung imaging patterns in connective tissue disease-associated interstitial lung disease impact prognosis and immunosuppression response","volume":"63","author":"Zheng","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2026.103635_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14176164","article-title":"High-Resolution CT findings in interstitial lung disease associated with connective tissue diseases: differentiating patterns for clinical Practice-A systematic review with meta-analysis","volume":"14","author":"Drimus","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2026.103635_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133131","article-title":"Pulmonary hypertension in patients with Sj\u00f6gren's syndrome: gender differences in cardiovascular risk factors and instrumental data","volume":"428","author":"Coppi","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2026.103635_bib68","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.07.035","article-title":"Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study","volume":"145","author":"Khan","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2026.103635_bib69","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ajh.21753","article-title":"Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis","volume":"85","author":"Adams","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jaut.2026.103635_bib70","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/jnci\/djh313","article-title":"Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas","volume":"96","author":"Feng","year":"2004","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126001137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126001137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:06:59Z","timestamp":1793045219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":70,"alternative-id":["S0896841126001137"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103635","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of clinical-immunologic clusters and anti-RNP\/Ro52 antibody profiles with prognostic trajectories in primary Sj\u00f6gren's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103635"}}